Exciting new research has shed light on a fascinating link between our digestive system and muscle health, offering fresh insights into Duchenne muscular dystrophy (DMD).
Key Findings:
DMD is traditionally known as a genetic condition where a lack of the protein dystrophin causes muscles to progressively weaken and break down. However, scientists are now discovering that the gut microbiome, otherwise known as the massive community of microbes living within our intestines, produce “good bacteria” and might play a surprisingly active role in how certain disorders, like DMD, progress.
In a study published in the Journal of Translational Medicine, researchers in Italy investigated this “gut-muscle axis” by focusing on a major group of beneficial gut microbes called the Bacteroides family. Normally, these helpful bacteria break down complex plant carbohydrates and produce short-chain fatty acids (SCFAs) that help regulate metabolism and inflammation. When looking closely at stool samples from 11 human DMD patients and 12 healthy individuals (as well as comparing DMD mice to healthy control mice), the team discovered that several Bacteroides species were significantly depleted in those with DMD. One specific bacterium called Bacteroides vulgatus was particularly low.
This microbial imbalance led to a major drop in a commendamide, a protective lipid molecular which is beneficial for muscle health. Commendamide is produced by these missing Bacteroides (bacteria). The researchers found that when commendamide levels are low, muscles are left more vulnerable. They discovered that a specific type of iron-driven cell death, known as ferroptosis, is highly active in DMD muscles. In DMD muscle tissues, gene expression that promote this type of cellular damage were elevated, while the gene expression that protects against it were significantly reduced.
The good news is that restoring these missing pieces shows real promise. Previous experiments in mice have shown that repairing the gut microbiome improved overall muscle strength. In this latest study, when researchers treated mouse muscle cells and myotubes (cells that mature into muscle fibers) directly with commendamide, it successfully protected the cells from damage by boosting their natural antioxidant mechanisms. The researchers note that these discoveries open the door to exploring bacteria-derived molecules, or “postbiotics,” as potential future therapies to help shield muscles and combat DMD.
Defeat Duchenne Canada will break down recent medical journal publications to keep our Duchenne community up to date on the rapidly changing Duchenne landscape. Have a question or comment related to the publication? Contact us at [email protected].
Want to know more about Duchenne Research?
Scientists and medical experts have been tirelessly pursuing diverse approaches to defeat Duchenne muscular dystrophy. From tackling the root cause to alleviating symptoms, the field of research is vast and promising. Explore the various strategies being developed and tested, and gain insights into the future of muscular dystrophy treatment: